317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision
The Readout Loud
00:00
The Rise of AI in Venture Capital and Significant Mergers
This chapter discusses the increasing interest of venture capital in artificial intelligence, especially in drug development. It highlights a key merger in the industry and underscores the importance of technical leadership in guiding investments.
Transcript
Play full episode
